RBC Capital analyst Brian Abrahams maintained a Hold rating on Incyte (INCY – Research Report) yesterday and set a price target of $74.00. The ...

In a report released today, Gregory Renza from RBC Capital maintained a Buy rating on Perspective Therapeutics (CATX – Research Report). The company’s shares closed yesterday at $6.96. Don't Miss our ...

Stock futures hovered near the flatline on Tuesday evening, as investors looked toward a key earnings report from tech giant ...

RBC Capital analyst Manjari Dhar initiated coverage of J Sainsbury (JSAIY) with an Outperform rating and 300 GBp price target ...

RBC Capital initiated coverage of Tesco (TSCDY) with a Sector Perform rating and 375 GBp price target The company has a ...

Shares of Imperial Brands (LON: IMB) rose on Tuesday after the tobacco and next-generation products (NGP) company posted ...

Two Arlington defense tech firms are joining up through an all-stock deal with an enterprise value of roughly $4.1 billion.

Yet there is another force that could deter Trump from some of his most extreme instincts: the $50 trillion US stock market.

The Reserve Bank board has signalled that a rate cut in either February or April is highly unlikely, saying it needs to see ...

Footage of a man being shoved into a wall by a police officer before being dragged through a front yard has been shared on social media, with SA Police confirming a formal complaint has been made ...

Bonus Jun 12, 2017 Jun 13, 2017 Apr 18, 2017 Bonus Ratio: 1 share(s) for every 10 shares held Rights May 24, 2011 May 25, 2011 May 21, 2009 Rights ratio: 1 share for every 1 held at a price of Rs 80.0 ...